Home > Financial Ratios > NGL FINECHEM

NGL FINECHEM
Working Capital/Sales

    Back to All Ratios
NGL FINECHEM is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for NGL FINECHEM
Please provide your vote to see the results

NGL FINECHEM Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Working Capital/Sales(x) 3.963.192.692.662.94

What is the latest Working Capital/Sales ratio of NGL FINECHEM ?

The latest Working Capital/Sales ratio of NGL FINECHEM is 3.96 based on Mar2026 Consolidated results.
Year Working Capital/Sales
Mar20263.96
Mar20253.19
Mar20242.69
Mar20232.66
Mar20222.94

How is Working Capital/Sales of NGL FINECHEM Trending?

Years Working Capital/Sales % Change
Mar2026 3.96
24.14
Mar2025 3.19
18.59
Mar2024 2.69
1.13
Mar2023 2.66
-9.52
Mar2022 2.94 -

Other Financial Ratios of NGL FINECHEM


Compare Working Capital/Sales ratio of peers of NGL FINECHEM

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NGL FINECHEM ₹1,628.3 Cr -8.5% -5.5% 84% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,684.0 Cr -0.2% -4.9% 5.5% Stock Analytics
DIVIS LABORATORIES ₹242,904.0 Cr 1.3% -2.3% 38.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹172,213.0 Cr -1.5% -5.8% 29.3% Stock Analytics
CIPLA ₹106,138.0 Cr 0.1% -4.2% -14.3% Stock Analytics
DR REDDYS LABORATORIES ₹103,304.0 Cr 1.9% 5.7% 0.4% Stock Analytics


NGL FINECHEM Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NGL FINECHEM

-8.5%

-5.5%

84%

SENSEX

0.9%

-0.8%

-10.5%


You may also like the below Video Courses